🇺🇸 FDA
Patent

US 9782398

Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

granted A61KA61K31/473A61K31/4745

Quick answer

US patent 9782398 (Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof) held by Neurocrine Biosciences, Inc. expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/473, A61K31/4745, A61K31/519, A61K31/551